CFM
IXHL icon

Catalyst Funds Management’s Incannex Healthcare IXHL Stock Holding History

Catalyst Funds Management’s Portfolio IXHL Stock Details IXHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2
Closed -$100 – 798
2024
Q3 		$100 Hold
2
– – ﹤0.01% 1267
2024
Q2 		$147 Hold
2
– – ﹤0.01% 1137
2024
Q1 		$180 Buy
+2
New +$240 ﹤0.01% 1081

Other funds holding IXHL

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Catalyst Funds Management's IXHL Position: Q4 2024 in Review

Catalyst Funds Management sold out of Incannex Healthcare (IXHL) in Q4 2024, closing a stake of 2 shares — an estimated $100 sold.

Catalyst Funds Management first reported a position in IXHL in Q1 2024 and held it in 3 quarters. The position peaked at $180 in Q1 2024. 7 funds tracked by Wall St. Rank hold IXHL as of Q4 2024.

  • Catalyst Funds Management reported no remaining Incannex Healthcare position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 2 Incannex Healthcare shares in Q4 2024, an estimated $100.
  • Catalyst Funds Management first reported a position in Incannex Healthcare in Q1 2024 and held it in 3 quarters.
  • Catalyst Funds Management's Incannex Healthcare position peaked at $180 in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Incannex Healthcare as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.